Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eslicarbazepine acetate adjunctive therapy for partial-onset seizures in elderly patients
2009-012587-14Phase 3Completed
- Sponsor
- BIAL
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of eslicarbazepine acetate in epilepsy and Focal onset seizure, sponsored by BIAL. Primary endpoint: Primary safety endpoint. Started Oct 2009; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
epilepsyFocal onset seizure
Beyond the preview
Go deeper on 2009-012587-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012587-14.